News & Analysis on Clinical Trial Services & Contract Research And Development
China-based Natural Pharmatech has formed its first research contract with a Japanese company, Kobayashi Pharmaceutical - another step forward in Natural Pharmatech's plans to bring its botanical R&D services to the global stage.
The number of new drug submissions has halved since 1995, while at the same time, pharma companies are spending three times as much money on R&D - a hole this industry needs to dig itself out of, and fast.
A new drug currently being trialed in the US to treat cancer could also be used to fight bird flu, according to researchers.